articleOrganic Process Research & DevelopmentDec 14, 2006Closed access

Perspective on Solvent Use in the Pharmaceutical Industry

GlaxoSmithKline (United Kingdom)

Indexed incrossref

Abstract

Solvent use consistently accounts for between 80 and 90% of mass utilization in a typical pharmaceutical/fine chemicals (non-polymer) batch chemical operation. Moreover, within these operations, solvents play a dominant role in the overall toxicity profile of any given process; i.e. on a mass basis, solvents account for the largest proportion of chemicals of concern used in the process. However, for the typical synthetic organic chemist, solvents are just a medium in which a reaction takes place; the interest is in the reactivity and building of a molecule, not in the means by which this is carried out. So, in a typical retrosynthetic analysis, solvent and solvent-reactant interactions, separability, and…

Citation impact

724
total citations
FWCI
6.34
Percentile
100%
References
13
Citations per year

Authors

3

Topics & keywords

Keywords
  • Solvent
  • Chemistry
  • Reactivity (psychology)
  • Biochemical engineering
  • Organic chemistry
  • Process (computing)
  • Mass transfer
  • Process engineering
UN Sustainable Development Goals
  • Industry, innovation and infrastructure
No related works found for this paper.

Funding